Abstract Information



Late breaker deadline : on request – strict conditions to be complied with.


In the online process you will first need to create a “Submitter Account”.

Following the creation of the submitter account you will receive an email with your personal access code.
The submission process requires to identify the abstract submitter and the main author (this may be the same person or two different persons).
The system will allow you to start drafting the abstract and to work on it including interruptions, and to save it as often as you wish as a draft before eventually submitting the final version.

General Conditions for Submission of Abstracts
Submission of an abstract implies the commitment that the presenting author registers for the EUROGIN 2018 Congress and that financial resources to attend are available; 

  1. Authors are requested to register within 10 days after having received their provisional notification of acceptance. Abstracts of authors not registered by September 15, 2018 will not be taken into consideration for the final program.
    Abstract presenters who would like to benefit from the early bird registration rate (deadline is June 30) are advised to submit their abstract before June 20, 2018 and send a short notice to This email address is being protected from spambots. You need JavaScript enabled to view it. . They will then receive notification of acceptance/refusal which will allow them to register at the early bird rate.
    If the abstract presenter is registered with a group, please inform the Congress Secretariat at: This email address is being protected from spambots. You need JavaScript enabled to view it. and indicate the person who booked the group registration.
  2. Abstracts must be submitted and presented in ENGLISH
  3. Abstracts should be prepared in accordance to the instructions below and submitted through the online system. Abstracts should comply with the editing instructions;
  4. For proffered papers (for Oral Communications sessions or Poster presentation), only ONE abstract is allowed per person duly registered for the congress;
  5. Original scientific material is welcome and preference is given to recent findings not yet published at the date of the Congress;
  6. Abstracts will be peer reviewed and evaluated by experts in one of the categories (topics) listed; they will be allocated for oral or poster presentation. Authors who do not wish to be considered for oral presentation are requested to indicate this when submitting. However, please note, that the Scientific Committee will make the final decision for the mode of presentation;
  7. The final decision of the Scientific Committee will be announced within 2 weeks after the abstract submission deadline (within 3 working days for late breaker abstracts).
  8. Authors agree that their abstract will be published in the congress abstract book (pdf document, no printed document will be issued)
  9. All accepted abstract submitters will receive confirmation by email. Please do not forget to indicate your correct email address and telephone number when submitting your abstract, as well as the email addresses of the main author and the presenter (the author who will present the paper at the conference). The main author and the presenter can be the same person. They may also be identical to or different from the submitter);
  10. The main author and the presenter must be identified (by ticking the corresponding boxes)
  11. For further information and assistance please contact the scientific secretariat at This email address is being protected from spambots. You need JavaScript enabled to view it.

Abstract Editing Instructions  

  1. Abstracts must be submitted through the online submission system;
  2. Maximum length (body of abstract): 2700 characters;
  3. The title should be written in UPPER CASE (capitals); (keep it as short as possible, clearly indicating the nature of the investigation. ;
  4. Please avoid complex mathematical formulae; the system allows to insert simple tables.
  5. Abstracts should be structured in at least three sections, clearly mentioned as such: Background/Objectives – Methods – Results (optional) – Conclusions. References may be mentioned.
  6. All authors (main author and co-authors) should be listed with their last names (family names) and their first name(s). The published version will only mention the initial(s) of the first name(s).ONE author must be identified as the PRESENTER; the presenter commits to registering as a delegate (except if she/he is an invited speaker), to attend the congress and present the abstract.
  7. Please indicate professional addresses of all authors: Name of hospital, unit or laboratory, city and country in lower case. No other indications are to be given. Different affiliations will be automatically numbered;
  8. Do not indent spaces on the first line of each paragraph. No space should be inserted between paragraphs. Use international standards for scientific articles;
  9. Only standard abbreviations may be used without definition. Data must be given in units widely used in literature;
  10. Only essential references should be included and put in brackets at the end of the abstract: Numbers in the text may refer to them;
  11. Drugs must be identified by their generic names

Abstract Topics   

For review purposes, abstracts are classified according to the following list. Select only 1 topic on our submission form: 

  1. Viral and molecular biology
  2. Epidemiology and natural history
  3. Pathogenesis
  4. Immunology
  5. HPV prophylactic vaccines
  6. HPV therapeutic vaccines
  7. Immunotherapy - Immuno-oncology - New treatments
  8. HPV testing
  9. HPV screening
  10. Self-sampling
  11. Genotyping
  12. Molecular markers
  13. Screening for women difficult to reach
  14. Screening methods
  15. Liquid based cytology
  16. Automation in cytology
  17. Methylation
  18. Microbiome
  19. Serology
  20. New technologies
  21. Diagnostic procedures / management
  22. Colposcopy
  23. Cervical neoplasia
  24. Vaginal neoplasia
  25. Vulvar diseases and neoplasia
  26. Anal neoplasia
  27. Oral HPV infection
  28. HPV and oropharynx / Head and neck cancer
  29. HPV and associated skin diseases
  30. Genital warts
  31. Sexually transmitted diseases and HIV infection
  32. Conventional therapies
  33. Economics and modelling
  34. Advocacy, acceptability and psychology
  35. Health education
  36. Low resource settings
  37. Public health


EUROGIN (EUropean Research Organisation on Genital Infection and Neoplasia) brings together clinicians and scientists whose work is related to genital infections and neoplasia.